TipRanks
Advertisement
Advertisement
AB Science’s Masitinib MS Trial Update: What Suspended Phase 3 Activity Means for Investors
PremiumCompany AnnouncementsAB Science’s Masitinib MS Trial Update: What Suspended Phase 3 Activity Means for Investors
6M ago
AB Science granted U.S. patnet for masitinib in treatment of SCD
Premium
The Fly
AB Science granted U.S. patnet for masitinib in treatment of SCD
10M ago
AB Science Reports Key Developments and Financial Results
Premium
Company Announcements
AB Science Reports Key Developments and Financial Results
1y ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―